Drug Abuse in Sports SUBJECT FORENSIC SCIENCE

Total Page:16

File Type:pdf, Size:1020Kb

Drug Abuse in Sports SUBJECT FORENSIC SCIENCE SUBJECT FORENSIC SCIENCE Paper No. and Title PAPER No. 9: Drugs of Abuse Module No. and Title MODULE No. 28: Drug Abuse in Sports Module Tag FSC_P9_M28 FORENSIC SCIENCE PAPER No. 9 : Drugs of Abuse MODULE No. 28 : Drug Abuse in Sports TABLE OF CONTENTS 1. Learning Outcomes 2. Introduction 3. Forensic Issues 4. Classification of Prohibited Substances in Sports 5. Some Notable Drugs used in Sports 6. Analytical Approach to detect Dope Drugs 7. Summary FORENSIC SCIENCE PAPER No. 9 : Drugs of Abuse MODULE No. 28 : Drug Abuse in Sports 1. Learning Outcomes After studying this module, you shall be able to know about The commonly use Drugs in sports. Classification and nature of the Drugs used in Sports. The techniques for detection of these drugs. 2. Introduction Drug abuse in sport is habitually called as “doping”. The universal word „dope‟ is being used both as a noun and as a verb. The word does not appear in this context before the twentieth century regardless of the practice of horse „nobbling‟, which was known well before this time. For example, the story of the famous trial of Daniel Dawson, publicly executed at Cambridge in 1812 for poisoning racehorses with arsenic. The abuse of drugs in an attempt to enhance performance in human sporting competitions is not new. For example, the Greek authors Phylostratos and Galen stated on the ethics of participants in the Olympics who would take any preparation to improve their performance. Roman gladiators were often intoxicated to make their fights more vigorous and gruesome as demanded by the spectators. The effect of drugs on performance is often exceptionally difficult to determine, and there is little conclusive available work for any species. The results that have been published are often contradictory as some of the workers advocate an increase in the competitor‟s performance and others suggest no improvement. The assessment systems used to evaluate the effect of drugs may not sufficiently relate to the appropriate sporting performance, such as increase in muscle strength and sprint running. Moreover, athletes may take far larger amounts of drugs than would be ethically acceptable in most human experiments. The toxic side-effects of drugs are less difficult to ascertain, but the conclusions drawn from the available data are often contingent. However, there is sufficient evidence of the harmful effects when certain drugs are misused to validate their prohibition from sports competitions. In human sports, the main monitoring body is International Olympic Committee (IOC). Nevertheless, since 1999, doping concerns have been taken over by the World Anti-Doping Agency (WADA). FORENSIC SCIENCE PAPER No. 9 : Drugs of Abuse MODULE No. 28 : Drug Abuse in Sports 3. Forensic Issues For most substances, the mere presence of the substance or an analytic metabolite in the biological fluid sampled constitutes an offence, but for some substances there is a reporting threshold. If the drug is detected, but it is less than the reporting threshold, no offence is reasoned to have occurred. Multifaceted rules apply to some of the substances, not least because some have therapeutic uses. The obligation is on the athlete to obtain a „Therapeutic Use Exemption‟ for certain categories of substances, with the substances covered under this possible exemption made clear in the WADA list. The WADA list also recognizes that some anabolic agents and hormones are produced endogenously. The fundamental rationale is that, an offence is considered to have occurred if one or more of these prohibited substances are detected in an athlete‟s specimen at a level outside of that which is considered to be the normal range in humans for the substance. For some substances, offences apply both in-competition or out of- competition, whereas for others an offence applies only if the substance is detected in-competition. For some sports, specific classes of substances are prohibited. For example, beta-blockers are prohibited in-competition in sports such as shooting, billiards and gymnastics. Alcohol is prohibited in-competition for sports such as motorcycling, power boating and archery. The emphasis when prohibiting use of a substance is on whether or not the use of a substance or method is proposed to enhance sport performance. The position regarding excessive quantities of normal nutrients is much argued. Although they are not currently included in a prohibited list, there is no hesitation that certain vitamins, notably B1, C and E and also Creatine have been used in large doses with the purpose of affecting performance. 4. Classification of Prohibited Substances in Sports 4.1 Stimulants This group of drugs includes psychomotor stimulants, sympathomimetic amines and other diverse CNS stimulants. They may produce alertness, wakefulness and an increase in the ability to concentrate. In addition they may improve the competence to exercise strenuously or produce a decreased sensitivity to pain. These effects are potentially of benefit to a wide variety of sports involving sustained physical and mental activity. FORENSIC SCIENCE PAPER No. 9 : Drugs of Abuse MODULE No. 28 : Drug Abuse in Sports 4.1.1 Amphetamines: Amphetamines are stimulants that include several structurally related drugs dextroamphetamine, methamphetamine, Phenmetrazine, and methyl phenidate. Physicians prescribe these drugs on a short term basis for treatment of obesity and also to treat narcolepsy and minimal brain dysfunction in children. 4.1.2 Cocaine: Cocaine, also a Central Nervous System Stimulant, when snorted, affects the brain within few minutes, the peak effect come within 15 – 20 minutes. When injected cocaine takes about 15 seconds to affect the brain. The euphoria following cocaine use is in some ways similar to the intense euphoria following an outstanding athletic performance. Both are in part facilitated through the “pleasure brain”. The individual feels energetic and hyper alert. 4.1.3 Sympathomimetic Amines: Sympathomimetic Amines are group of stimulants of which ephedrine is an example. However, Pseudoephedrine and phenylpropanolamine, which used to be in banned list of WADA is no more in the same category. The ephedrine is also found in low doses in cough, cold and sinus medications. Because these medicines are broadly used by the people as over the counter drugs, they are effortlessly abused by competing athletes‟ for their stimulant effects. Prohibited stimulants: Adrafinil, Adrenaline, Amfepramone, Amphetamine, Amfetaminil, Amiphenazole, Benzfetamine, Benzylpiperazine, Bromantane, Cathine, Clobenzorex, Cocaine, Cropropamide, Crotetamide, Cyclazodone, Dimethylamphetamine, Ephedrine, Etamivan, Etilamphetamine, Etilefrine, Famprofazone, Fenbutrazate, Fencamfamin, Fencamine, Fenetylline, Fenfluramine, Fenproporex, Furfenorex, Heptaminol, P-Hydroxyamphetamine, Isometheptene, Levmethamphetamine, Meclofenoxate, Mefenorex, Mephentermine, Mesocarb, Methylenedioxyamphetamine, Methamphetamine, Methylephedrine, Methylphenidate, Modafinil, Nikethamide, Norfenefrine, Norfenfluramine, Octopamine, Ortetamine, Oxilofrine, Pemoline, Pentetrazol, Phendimetrazine, Phenmetrazine, Phenpromethamine, Phentermine, 4- Phenylpiracetam, Prolintane, Propylhexedrine, Selegiline, Sibutramine, Strychnine, Tuaminoheptane and other substances with a similar chemical structure or similar biological effect(s). FORENSIC SCIENCE PAPER No. 9 : Drugs of Abuse MODULE No. 28 : Drug Abuse in Sports 4.2 Narcotics Analgesics Narcotics are derivatives of Opium and consist of powerful painkiller drugs. Narcotics are not perceived as ergogenic drug. However, their use, misuse and abuse potential in sports may be high because of pressures on the athlete to perform competitively despite varied musculo-skeletal injuries. The pressure on the athletes to perform well is so intense that they sometimes turn to narcotics as an emotional escape. These drugs are banned so as to decrease the risk of tragic conditions. Prohibited Narcotics analgesics: Buprenorphine, Dextromoramide, Diamorphine (Heroin), Fentanyl and its derivatives, Hydromorphone, Methadone, Morphine, Oxycodone, Oxymorphone, Pentazocine, Pethidine 4.3 Anabolic Steroids Anabolic steroids are synthetic derivatives of the natural male hormones Testosterone, which is produced principally by testes in males and is responsible for androgenic (masculinizing) and anabolic (tissue- building) effects. The abuse of anabolic steroids has historic foundations in man‟s aspiration to create a body building “wonder drug”. This group of drugs is responsible for the most pervasive abuse of drugs in sports. In human sport, anabolic steroids are used as bodybuilding drugs, occasionally in very large quantities, in events such as weightlifting and shot-putting. There are generally two chemical types based upon the androstane and estrane ring systems: those with a 17α-alkyl group, which are active orally but possess hepatotoxicity, and 19-nor derivatives administered by injection. Although steroidal estrogens and some stilbenes reputedly possess anabolic activity and are engaged in beef production, they do not appear to be used as doping agents. Anabolic Steroids reverse the negative or catabolic effects of exercise have on muscle. During exercise the adrenal glands naturally secrete glucocorticoids that induce muscle breakdown. Anabolic Steroids minimize this catabolism and thus build muscles. FORENSIC SCIENCE PAPER No. 9 : Drugs of Abuse MODULE No. 28 : Drug Abuse in Sports 4.3.1 Exogenous Anabolic Agents: Androstenediol, Androstenedione,
Recommended publications
  • AO-Klasifikácia Faktúr →Zlomeniny
    AO-klasifikácia faktúr →zlomeniny. AOP-syndróm – skr. syndroma adipositas–oligomenorrhoea–parotis. aorta – [g. aorté srdcovnica] srdcovnica. Začína sa z ľavej komory a vystupuje kraniálne aţ do výšky 2. pravého sternokostálneho kĺbu ako aorta ascendens, pokračovaním je oblúk arcus aortae, aorta descendens, aorta thoracia a aorta abdominalis. Aorta ascendens – začína sa v ľavej komore nad polmesiačikovitými chlopňami a skoro celá sa nachádza v perikarde. Je dlhá asi 4 – 5 cm, jej priemer je 22 – 30 mm. Ihneď nad chlop-ňami je následkom spätných nárazov krvi mierne vydutá do tzv. sinus aortae, výraznejšie u starších osôb. Oddiely a. obsahujúce sinus aortae sa nazývajú bulbus aortae. U starších osôb býva následkom nárazov krvi širší aj koncový úsek vzostupnej a. pred jej prechodom do oblúka, tzv. sinus maximus (quartus) aortae. Tu býva u starších osôb a. často rozširená. A. ascendens, ako aj začiatok arcus aortae majú špeciálne vasa vasorum pochádzajúce z vencovitých tepien (aa. cardiaortales). Tento úsek osobitne patogeneticky rizikový. Začiatok aorta ascendens je ešte obalený vo vagina serosa arteriarum, kt. tvorí na ventrálnom obvode a. priečnu krkvu podloţenú subseróznym tukovým väzivom (Concatova-Bacceli tuková krkva). Vnútri vagina arteriarum je aorta ascendens a začiatrok a. pulmonalis spojené tuhým väzivom (vincula aortae Rindfleischi). Výstup aorta ascendens kryje spredu začiatok a. pulmonalis, ventrálne a vpravo je auricula dextra, dorzálne je uloţený r. dexter a. pulmonalis. Kraniálne vpravo od a. je v. cava superior, vľavo kmeň a. pulmonalis. Z ventrálneho a ľavého sinus aortae sa začína a. coronaria cordis dextra et sinistra. Aorta ascendens a arcus aortae Arcus aortae – je dlhý asi 6 cm, začína sa za sternom vo výške úponu 2.
    [Show full text]
  • The 2006 Prohibited List International Standard
    The World Anti-Doping Code THE 2006 PROHIBITED LIST INTERNATIONAL STANDARD The official text of the Prohibited List shall be maintained by WADA and shall be published in English and French. In the event of any conflict between the English and French versions, the English version shall prevail. This List shall come into effect on 1 January 2006. THE 2006 PROHIBITED LIST WORLD ANTI-DOPING CODE Valid 1 January 2006 The use of any drug should be limited to medically justified indications SUBSTANCES AND METHODS PROHIBITED AT ALL TIMES (IN- AND OUT-OF-COMPETITION) PROHIBITED SUBSTANCES S1. ANABOLIC AGENTS Anabolic agents are prohibited. 1. Anabolic Androgenic Steroids (AAS) a. Exogenous* AAS, including: 1-androstendiol (5α-androst-1-ene-3β,17β-diol ); 1-androstendione (5α- androst-1-ene-3,17-dione); bolandiol (19-norandrostenediol); bolasterone; boldenone; boldione (androsta-1,4-diene-3,17-dione); calusterone; clostebol; danazol (17α-ethynyl-17β-hydroxyandrost-4-eno[2,3-d]isoxazole); dehydrochlormethyltestosterone (4-chloro-17β-hydroxy-17α-methylandrosta- 1,4-dien-3-one); desoxymethyltestosterone (17α-methyl-5α-androst-2-en- 17β-ol); drostanolone; ethylestrenol (19-nor-17α-pregn-4-en-17-ol); fluoxymesterone; formebolone; furazabol (17β-hydroxy-17α-methyl-5α- androstano[2,3-c]-furazan); gestrinone; 4-hydroxytestosterone (4,17β-dihydroxyandrost-4-en-3-one); mestanolone; mesterolone; metenolone; methandienone (17β-hydroxy-17α- methylandrosta-1,4-dien-3-one); methandriol; methasterone (2α, 17α- dimethyl-5α-androstane-3-one-17β-ol); methyldienolone
    [Show full text]
  • UFC PROHIBITED LIST Effective June 1, 2021 the UFC PROHIBITED LIST
    UFC PROHIBITED LIST Effective June 1, 2021 THE UFC PROHIBITED LIST UFC PROHIBITED LIST Effective June 1, 2021 PART 1. Except as provided otherwise in PART 2 below, the UFC Prohibited List shall incorporate the most current Prohibited List published by WADA, as well as any WADA Technical Documents establishing decision limits or reporting levels, and, unless otherwise modified by the UFC Prohibited List or the UFC Anti-Doping Policy, Prohibited Substances, Prohibited Methods, Specified or Non-Specified Substances and Specified or Non-Specified Methods shall be as identified as such on the WADA Prohibited List or WADA Technical Documents. PART 2. Notwithstanding the WADA Prohibited List and any otherwise applicable WADA Technical Documents, the following modifications shall be in full force and effect: 1. Decision Concentration Levels. Adverse Analytical Findings reported at a concentration below the following Decision Concentration Levels shall be managed by USADA as Atypical Findings. • Cannabinoids: natural or synthetic delta-9-tetrahydrocannabinol (THC) or Cannabimimetics (e.g., “Spice,” JWH-018, JWH-073, HU-210): any level • Clomiphene: 0.1 ng/mL1 • Dehydrochloromethyltestosterone (DHCMT) long-term metabolite (M3): 0.1 ng/mL • Selective Androgen Receptor Modulators (SARMs): 0.1 ng/mL2 • GW-1516 (GW-501516) metabolites: 0.1 ng/mL • Epitrenbolone (Trenbolone metabolite): 0.2 ng/mL 2. SARMs/GW-1516: Adverse Analytical Findings reported at a concentration at or above the applicable Decision Concentration Level but under 1 ng/mL shall be managed by USADA as Specified Substances. 3. Higenamine: Higenamine shall be a Prohibited Substance under the UFC Anti-Doping Policy only In-Competition (and not Out-of- Competition).
    [Show full text]
  • Doping Control of Athletes
    trends in analytical chemistry, vol. 7, no. IO, I988 375 trends Doping control of athletes E. G. de Jong*, I?. A. A. Maes and The definition of the Council of Europe for doping J. M. van Rossum is2: Utrecht, Netherlands ‘The administration to or the use by a healthy indi- vidual in any way of compounds which are not natu- History ral to the organism or the use of physiological com- The origin of the word doping is not certain. It first pounds in abnormal doses or in an abnormal way appeared in the English dictionaries at the end of the with the only purpose to artificially and dishonestly nineteenth century. The first reference to the use of influence the performance of this person during doping by athletes was in 1864 during swimming competition.’ competitions that were held in the canals of Amster- Another possible definition is: dam. The use of what is known as a ‘speedball’, a ‘The use of compounds which are not synthesized mixture of heroine and cocaine, by cyclists was de- by the human body or the use of endogenous com- scribed in 1869. In 1904 the Russian chemist pounds in excessive doses with the aim to improve Bukowski was able to identify some alkaloids in the performance in sport competitions.’ saliva of horses’. A simpler definition is: Australia was the first country to take measures ‘The use of forbidden drugs. ’ against doping in sports in 1962, and England fol- The last definition can only be used when we have lowed with the drugs bill in 1964.
    [Show full text]
  • 2008 Prohibited List
    The World Anti-Doping Code THE 2008 PROHIBITED LIST INTERNATIONAL STANDARD The official text of the Prohibited List shall be maintained by WADA and shall be published in English and French. In the event of any conflict between the English and French versions, the English version shall prevail. This List shall come into effect on 1 January 2008 The Prohibited List 2008 September 22, 2007 THE 2008 PROHIBITED LIST WORLD ANTI-DOPING CODE Valid 1 January 2008 The use of any drug should be limited to medically justified indications SUBSTANCES AND METHODS PROHIBITED AT ALL TIMES (IN- AND OUT-OF-COMPETITION) PROHIBITED SUBSTANCES S1. ANABOLIC AGENTS Anabolic agents are prohibited. 1. Anabolic Androgenic Steroids (AAS) a. Exogenous* AAS, including: 1-androstendiol (5α-androst-1-ene-3β,17β-diol ); 1-androstendione (5α- androst-1-ene-3,17-dione); bolandiol (19-norandrostenediol); bolasterone; boldenone; boldione (androsta-1,4-diene-3,17-dione); calusterone; clostebol; danazol (17α-ethynyl-17β-hydroxyandrost-4-eno[2,3-d]isoxazole); dehydrochlormethyltestosterone (4-chloro-17β-hydroxy-17α-methylandrosta- 1,4-dien-3-one); desoxymethyltestosterone (17α-methyl-5α-androst-2-en- 17β-ol); drostanolone; ethylestrenol (19-nor-17α-pregn-4-en-17-ol); fluoxymesterone; formebolone; furazabol (17β-hydroxy-17α-methyl-5α- androstano[2,3-c]-furazan); gestrinone; 4-hydroxytestosterone (4,17β- dihydroxyandrost-4-en-3-one); mestanolone; mesterolone; metenolone; methandienone (17β-hydroxy-17α-methylandrosta-1,4-dien-3-one); methandriol; methasterone (2α, 17α-dimethyl-5α-androstane-3-one-17β-ol);
    [Show full text]
  • Southern Africa Pga Tour Npc Anti-Doping Program Guide
    SOUTHERN AFRICA PGA TOUR NPC (Association Incorporated under Section 21) ANTI-DOPING PROGRAM GUIDE 2018 Sunshine Tour Anti-Doping Program Guide 2018 Page 1 Contents Page Section 1 Player Guide to the Anti-Doping Program 3 Section 2 Player Guide to Prohibited Substances 7 Section 3 Sunshine Tour Anti-Doping Program 14 Section 4 Anti-Doping Program Definitions 25 Section 5 Sunshine Tour List of Prohibited Substances and Methods 28 Section 6 Therapeutic Use Exemption Declaration & Application 36 Section 7 Player Resources 36 Sunshine Tour Anti-Doping Program Guide 2018 Page 2 SECTION 1 PLAYER GUIDE TO THE SUNSHINE TOUR ANTI DOPING PROGRAM Who is covered by the Sunshine Tour’s Anti-Doping Program? The anti-doping program (the “Program”) was developed in co-operation with the South African Institute for Drug-Free Sport (“SAIDS”) to protect the integrity that is inherent in the sport of golf and to ensure the health and safety of all players. SAIDS was established as a statutory body by the South African Institute for Drug-Free Sport Act no. 14 of 1997 as the independent National Anti-Doping Organisation for South Africa. The SUNSHINE TOUR recognises the independence and jurisdiction of SAIDS. All SUNSHINE TOUR members and BIG EASY TOUR members are bound by the Program. Additionally, any player who participates in a SUNSHINE TOUR co-sanctioned, sanctioned, approved or coordinated tournament is bound by the Program. What substances and methods are prohibited? The World Anti-Doping Agency (WADA) List of Prohibited Substances and Methods (the “List”), in force at the time, defines what is prohibited and the SUNSHINE TOUR List of Prohibited Substances and Methods is based on the List.
    [Show full text]
  • Systematic Evaluation of 1-Chlorobutane for Liquid-Liquid Extraction of Drugs U
    Systematic evaluation of 1-chlorobutane for liquid-liquid extraction of drugs U. Demme1*, J. Becker2, H. Bussemas3, T. Daldrup4, F. Erdmann5, M. Erkens6, P.X. Iten7, H. Käferstein8, K.J. Lusthof9, H.J. Magerl10, L.v. Meyer11, A. Reiter12, G. Rochholz13, A. Schmoldt14, E. Schneider15, H.W. Schütz13, T. Stimpfl16, F. Tarbah17, J. Teske18, W. Vycudilik16, J.P. Weller18, W. Weinmann19 *On behalf of the “Workgroup Extraction“ of the GTFCh (Society of Toxicological and Forensic Chemistry, Germany) Institutes of Forensic Medicine of 1Jena, 2Mainz, 4Duesseldorf, 5Giessen, 7Zuerich (CH), 8Cologne, 10Wuerzburg, 11Munich, 12Luebeck, 13Kiel, 14Hamburg, 16Vienna (A), 18Hannover, 19Freiburg and 3Praxis Labormedizin Dortmund, 6Clin.-Chem. Central Laboratory, Aachen, 9Nat. For. Inst., Den Haag (NL), 15LKA Baden-Wuerttemberg, Stuttgart 17Dubai Police Dept. Introduction In systematic toxicological analysis (STA), chromatographic Experimental Buffer solutions (pH 9) were obtained by dissolving 10 g methods are widely used for the detection of drugs and other organic toxic substances in Na2HPO4 (VWR) in one liter of distilled water. 1-chlorobutane and methanol (analytical biological materials, such as blood, plasma, urine, hair and tissue samples. In most cases grade) were obtained from VWR International (Darmstadt, Germany). Drugs were the applied analytical methods like gas chromatography-mass spectrometry (GC/MS), purchased as pure compounds or as salts from chemical suppliers (Sigma high performance liquid chromatography with diode-array detection (HPLC/DAD), Deissenhofen/Germany and others) or from the pharmaceutical manufacturers and were HPLC/mass spectrometry (LC/MS), or thin-layer chromatography with remission first dissolved in methanol to achieve a concentration of 1 mg/mL. In some instances the spectroscopy (TLC/UV), require sample preparation by extraction prior to analysis.
    [Show full text]
  • Toxicology Reference Material
    toxicology Toxicology covers a wide range of disciplines, including therapeutic drug monitoring, clinical toxicology, forensic toxicology (drug driving, criminal and coroners), drugs in sport and work place drug testing, as well as academia and research. Those working in the field have a professional interest in the detection and measurement of alcohol, drugs, poisons and their breakdown products in biological samples, together with the interpretation of these measurements. Abuse and misuse of drugs is one of the biggest problems facing our society today. Acute poisoning remains one of the commonest medical emergencies, accounting for 10-20% of hospital admissions for general medicine [Dargan & Jones, 2001]. Many offenders charged with violent crimes, or victims of violent crime may have been under the influence of drugs at the time the act was committed. The use of mind-altering drugs in the work place, or whilst in control of a motor vehicle places others in danger [Drummer, 2001]. Performance enhancing drugs in sport make for an uneven playing field and distract from the core ethic of sportsmanship. Patterns of drug abuse around the world are constantly evolving. They vary between geographies; from one country to another and even from region to region or population to population within countries. With a European presence, a wide reaching network of global customers and distributors, and activate participation in relevant professional societies, Chiron is well positioned to develop and deliver relevant, and current standards to meet customer demand in this challenging field. Chiron AS Stiklestadvn. 1 N-7041 Trondheim Norway Phone No.: +47 73 87 44 90 Fax No.: +47 73 87 44 99 E-mail: [email protected] Website: www.chiron.no Org.
    [Show full text]
  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
    20558 Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DEPARMENT OF THE TREASURY Services, U.S. Customs Service, 1301 TABLE 1.ÐPHARMACEUTICAL APPEN- Constitution Avenue NW, Washington, DIX TO THE HTSUSÐContinued Customs Service D.C. 20229 at (202) 927±1060. CAS No. Pharmaceutical [T.D. 95±33] Dated: April 14, 1995. 52±78±8 ..................... NORETHANDROLONE. A. W. Tennant, 52±86±8 ..................... HALOPERIDOL. Pharmaceutical Tables 1 and 3 of the Director, Office of Laboratories and Scientific 52±88±0 ..................... ATROPINE METHONITRATE. HTSUS 52±90±4 ..................... CYSTEINE. Services. 53±03±2 ..................... PREDNISONE. 53±06±5 ..................... CORTISONE. AGENCY: Customs Service, Department TABLE 1.ÐPHARMACEUTICAL 53±10±1 ..................... HYDROXYDIONE SODIUM SUCCI- of the Treasury. NATE. APPENDIX TO THE HTSUS 53±16±7 ..................... ESTRONE. ACTION: Listing of the products found in 53±18±9 ..................... BIETASERPINE. Table 1 and Table 3 of the CAS No. Pharmaceutical 53±19±0 ..................... MITOTANE. 53±31±6 ..................... MEDIBAZINE. Pharmaceutical Appendix to the N/A ............................. ACTAGARDIN. 53±33±8 ..................... PARAMETHASONE. Harmonized Tariff Schedule of the N/A ............................. ARDACIN. 53±34±9 ..................... FLUPREDNISOLONE. N/A ............................. BICIROMAB. 53±39±4 ..................... OXANDROLONE. United States of America in Chemical N/A ............................. CELUCLORAL. 53±43±0
    [Show full text]
  • Anti-Doping Manual Revised Dec. 2018
    PGA TOUR Anti-Doping Program Manual REVISED DECEMBER 2018 Table of Contents How To Use This Manual .......................................................................................................................................................2 SECTION 1: Player Guide To Anti-Doping ...........................................................................................................................3 Who is covered by the Anti-Doping Program .........................................................................................................3 What substances and methods are banned ..........................................................................................................3 Am I liable for a prohibited substance in my body even if I did not intend to take the substance ........................3 What should players know about nutritional and health products ...................................................................3 Are there supplements that have been tested/certified as free from banned substances ........................3 What about medical treatment.................................................................................................................................4 What medications are permitted .............................................................................................................................4 Who conducts the testing and who will be tested ................................................................................................4 What are the steps in
    [Show full text]
  • Pharmacology of Stimulants Prohibited by the World Anti-Doping Agency (WADA)
    British Journal of Pharmacology (2008) 154, 606–622 & 2008 Nature Publishing Group All rights reserved 0007– 1188/08 $30.00 www.brjpharmacol.org REVIEW Pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA) JR Docherty Department of Physiology, Royal College of Surgeons in Ireland, Dublin, Ireland This review examines the pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA). Stimulants that increase alertness/reduce fatigue or activate the cardiovascular system can include drugs like ephedrine available in many over- the-counter medicines. Others such as amphetamines, cocaine and hallucinogenic drugs, available on prescription or illegally, can modify mood. A total of 62 stimulants (61 chemical entities) are listed in the WADA List, prohibited in competition. Athletes may have stimulants in their body for one of three main reasons: inadvertent consumption in a propriety medicine; deliberate consumption for misuse as a recreational drug and deliberate consumption to enhance performance. The majority of stimulants on the list act on the monoaminergic systems: adrenergic (sympathetic, transmitter noradrenaline), dopaminergic (transmitter dopamine) and serotonergic (transmitter serotonin, 5-HT). Sympathomimetic describes agents, which mimic sympathetic responses, and dopaminomimetic and serotoninomimetic can be used to describe actions on the dopamine and serotonin systems. However, many agents act to mimic more than one of these monoamines, so that a collective term of monoaminomimetic may be useful. Monoaminomimietic actions of stimulants can include blockade of re-uptake of neurotransmitter, indirect release of neurotransmitter, direct activation of monoaminergic receptors. Many of the stimulants are amphetamines or amphetamine derivatives, including agents with abuse potential as recreational drugs.
    [Show full text]
  • 2019 Prohibited List
    THE WORLD ANTI-DOPING CODE INTERNATIONAL STANDARD PROHIBITED LIST JANUARY 2019 The official text of the Prohibited List shall be maintained by WADA and shall be published in English and French. In the event of any conflict between the English and French versions, the English version shall prevail. This List shall come into effect on 1 January 2019 SUBSTANCES & METHODS PROHIBITED AT ALL TIMES (IN- AND OUT-OF-COMPETITION) IN ACCORDANCE WITH ARTICLE 4.2.2 OF THE WORLD ANTI-DOPING CODE, ALL PROHIBITED SUBSTANCES SHALL BE CONSIDERED AS “SPECIFIED SUBSTANCES” EXCEPT SUBSTANCES IN CLASSES S1, S2, S4.4, S4.5, S6.A, AND PROHIBITED METHODS M1, M2 AND M3. PROHIBITED SUBSTANCES NON-APPROVED SUBSTANCES Mestanolone; S0 Mesterolone; Any pharmacological substance which is not Metandienone (17β-hydroxy-17α-methylandrosta-1,4-dien- addressed by any of the subsequent sections of the 3-one); List and with no current approval by any governmental Metenolone; regulatory health authority for human therapeutic use Methandriol; (e.g. drugs under pre-clinical or clinical development Methasterone (17β-hydroxy-2α,17α-dimethyl-5α- or discontinued, designer drugs, substances approved androstan-3-one); only for veterinary use) is prohibited at all times. Methyldienolone (17β-hydroxy-17α-methylestra-4,9-dien- 3-one); ANABOLIC AGENTS Methyl-1-testosterone (17β-hydroxy-17α-methyl-5α- S1 androst-1-en-3-one); Anabolic agents are prohibited. Methylnortestosterone (17β-hydroxy-17α-methylestr-4-en- 3-one); 1. ANABOLIC ANDROGENIC STEROIDS (AAS) Methyltestosterone; a. Exogenous*
    [Show full text]